Zomedica (NYSEAMERICAN:ZOM) Trading Down 0.7% – What’s Next?

Zomedica Corp. (NYSEAMERICAN:ZOM)’s share price dropped 0.7% on Friday . The stock traded as low as $0.12 and last traded at $0.12. Approximately 3,813,034 shares were traded during trading, a decline of 31% from the average daily volume of 5,537,491 shares. The stock had previously closed at $0.12.

Analyst Ratings Changes

Separately, Noble Financial upgraded Zomedica to a “strong-buy” rating in a research note on Monday, November 11th.

Zomedica Stock Performance

The company has a market cap of $117.40 million, a PE ratio of -2.00 and a beta of 1.03.

Hedge Funds Weigh In On Zomedica

A number of large investors have recently added to or reduced their stakes in ZOM. Jane Street Group LLC purchased a new stake in shares of Zomedica during the third quarter worth $25,000. Gabelli Funds LLC grew its stake in Zomedica by 125.0% during the 4th quarter. Gabelli Funds LLC now owns 225,000 shares of the company’s stock valued at $27,000 after acquiring an additional 125,000 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Zomedica by 142.9% in the 4th quarter. Wells Fargo & Company MN now owns 255,001 shares of the company’s stock valued at $31,000 after acquiring an additional 150,000 shares during the last quarter. Two Sigma Securities LLC acquired a new stake in Zomedica in the 4th quarter valued at about $32,000. Finally, LPL Financial LLC lifted its stake in Zomedica by 34.3% in the 4th quarter. LPL Financial LLC now owns 383,995 shares of the company’s stock worth $46,000 after purchasing an additional 98,020 shares in the last quarter. 8.95% of the stock is currently owned by institutional investors and hedge funds.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.